In the event of an inadvertent temperature excursion the following data may be used:
Neulasta may be exposed to room temperature (not above 30°C) for a maximum single period of up to 72 hours, after which it should be discarded.
The pre-filled syringe with the on-body injector may be exposed at room temperature for no longer than 36 hours prior to filling the on-body injector.
Accidental exposure to freezing temperatures for a single period of less than 24 hours does not adversely affect the stability of Neulasta.
Please also refer to the manufacturer’s product literature for recommended storage information at https://www.medicines.org.uk
Contact Amgen Ltd in cases where additional stability data is required. Refer to the current BNF for company contact details.